Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases

The development of rapid, noninvasive diagnostics to detect lung diseases is a great need after the COVID-2019 outbreak. The nanotechnology-based approach has improved imaging and facilitates the early diagnosis of inflammatory lung diseases. The multifunctional properties of nanoprobes enable bette...

Full description

Saved in:
Bibliographic Details
Published in:Nanomedicine (London, England) England), 2022-10, Vol.17 (25), p.1981-2005
Main Authors: Masanam, Hema Brindha, Perumal, Govindaraj, Krishnan, Saravanan, Singh, Sachin Kumar, Jha, Niraj Kumar, Chellappan, Dinesh Kumar, Dua, Kamal, Gupta, Piyush Kumar, Narasimhan, Ashwin Kumar
Format: Article
Language:English
Subjects:
Antineoplastic Agents
contrast agents
Contrast Media
COVID-19 - diagnostic imaging
COVID-19 Testing
Diagnostic Imaging - methods
Humans
imaging nanoparticles
inflammatory lungs diseases
medical imaging
Nanoparticles
Nanotechnology - methods
respiratory diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The development of rapid, noninvasive diagnostics to detect lung diseases is a great need after the COVID-2019 outbreak. The nanotechnology-based approach has improved imaging and facilitates the early diagnosis of inflammatory lung diseases. The multifunctional properties of nanoprobes enable better spatial–temporal resolution and a high signal-to-noise ratio in imaging. Targeted nanoimaging agents have been used to bind specific tissues in inflammatory lungs for early-stage diagnosis. However, nanobased imaging approaches for inflammatory lung diseases are still in their infancy. This review provides a solution-focused approach to exploring medical imaging technologies and nanoprobes for the detection of inflammatory lung diseases. Prospects for the development of contrast agents for lung disease detection are also discussed.
ISSN:1743-5889
1748-6963
DOI:10.2217/nnm-2021-0427